VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.
第一作者:
Samantha J,McClenahan
第一单位:
Departments of Anesthesiology (S.J.M., S.V.K., R.G., R.M.L., J.S.D.), Biochemistry (J.A.B.), Chemistry (C.N.K., J.C.W., I.M.R., C.D.W., G.A.S., C.W.L.), Pharmacology (E.L.D., C.D.W., C.W.L., C.H., O.B., J.S.D.), and Nephrology (A.T., R.H.), and Vanderbilt Institute of Chemical Biology (J.A.B., G.S., C.D.W., C.W.L., J.S.D.), Vanderbilt University, Nashville, Tennessee; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin (E.I.); and Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida (A.S.).
作者:
医学主题词
动物(Animals);基因文库(Gene Library);高通量筛选分析(High-Throughput Screening Assays);小鼠(Mice);钾(Potassium);钾通道阻滞剂(Potassium Channel Blockers);钾通道, 内向整流(Potassium Channels, Inwardly Rectifying)
DOI
10.1124/molpharm.121.000464
PMID
35246480
发布时间
2025-02-13
- 浏览0
Molecular pharmacology
357-370页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



